Probiotic Lactobacillus and Promotion of Tumor Growth: Difference between revisions
(Created page with "==Introduction== Image:Ebola1.jpg|thumb|300px|right|Electron micrograph of the Ebola Zaire virus. This was the first photo ever taken of the virus, on 10/13/1976. By Dr. F.A...") |
No edit summary |
||
| Line 1: | Line 1: | ||
==Introduction== | ==Introduction== | ||
Lactobacillus, a Gram-Positive, non spore forming firmicute, rod-shaped Bacilli bacterium inhabits the digestive tract of mammalian organisms, as a significant probiotic required for the digestion and breakdown of lactose in a stable gut microbiome. Lactobacillus is classified into 3 distinct groups based on metabolic pathways, Obligately Facultatively homofermentative, and Obligately heterofermentative, each are significantly different in the products produced by the metabolic pathways of each species. Lactobacillus is a lactic acid bacteria (LAB) capable of proliferating in environments of low pH, tolerating the pH level in mammalians gut microbiome, and break down lactose present in the environment, promoting a health gut microbiome. However, in novel research, it has been discovered that lactobacillus has detrimental effects lessing the efficiency of anticancer medications. | |||
==Genome and Regulation== | |||
== | ==Metabolism and Environmental Interaction== | ||
<br>Include some current research in each topic, with at least one figure showing data.<br> | <br>Include some current research in each topic, with at least one figure showing data.<br> | ||
== | ==Effects on the Gut and Digestive system== | ||
<br>Include some current research in each topic, with at least one figure showing data.<br> | <br>Include some current research in each topic, with at least one figure showing data.<br> | ||
== | ==Effect on chemotherapies and Cancer Treatments== | ||
<br>Overall paper length should be 3,000 words, with at least 3 figures.<br> | <br>Overall paper length should be 3,000 words, with at least 3 figures.<br> | ||
Revision as of 01:08, 2 March 2022
Introduction
Lactobacillus, a Gram-Positive, non spore forming firmicute, rod-shaped Bacilli bacterium inhabits the digestive tract of mammalian organisms, as a significant probiotic required for the digestion and breakdown of lactose in a stable gut microbiome. Lactobacillus is classified into 3 distinct groups based on metabolic pathways, Obligately Facultatively homofermentative, and Obligately heterofermentative, each are significantly different in the products produced by the metabolic pathways of each species. Lactobacillus is a lactic acid bacteria (LAB) capable of proliferating in environments of low pH, tolerating the pH level in mammalians gut microbiome, and break down lactose present in the environment, promoting a health gut microbiome. However, in novel research, it has been discovered that lactobacillus has detrimental effects lessing the efficiency of anticancer medications.
Genome and Regulation
Metabolism and Environmental Interaction
Include some current research in each topic, with at least one figure showing data.
Effects on the Gut and Digestive system
Include some current research in each topic, with at least one figure showing data.
Effect on chemotherapies and Cancer Treatments
Overall paper length should be 3,000 words, with at least 3 figures.
References
Edited by student of Joan Slonczewski for BIOL 238 Microbiology, 2009, Kenyon College.
